Our vision is to improve the lives of patients and families suffering from rare muscle disorders, including Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), by building the world’s leading muscle-focused, precision medicine company. In less than four years, we have matured into a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing drugs to treat […]

We are a preclinical-stage biopharmaceutical company pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs), that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Certain nucleotide repeat expansion diseases, such as Friedreich ataxia (FA), can result in reduced expression of specific mRNAs; in other diseases, such […]

We are a pharmaceutical company based in Jiangxi, China, specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (“TCMD”) products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. We have registered and obtained approval for 26 varieties of […]

(Note: This is a SPAC offering of ordinary shares and NOT units; most SPACs are unit offerings. This is the third special purpose acquisition company, or SPAC, also known as a blank-check company, created by Dragoneer Investment Group, whose early-stage investments have included Airbnb, Alibaba, DoorDash, Slack, Snowflake, Spotify and Uber. Incorporated in the Cayman […]

(Khosla Ventures Acquisition Co. III is offering shares of Class A common stock. This is not your typical SPAC unit offering.) We intend to focus our search for a target business addressing a large market opportunity with a highly differentiated, proprietary technology. (Note: Khosla Ventures Acquisition Co. III priced its SPAC IPO on March 23, […]

Khosla Ventures Acquisition Co. II is offering shares of Class A common stock. Most SPACs are unit offerings of stock and warrants. We intend to focus our search for a target business addressing a large market opportunity with a highly differentiated, proprietary technology. Our founding team is Vinod Khosla, the founder of Khosla Ventures; CEO […]

We intend to initially focus our search on identifying a prospective target business within the financial services and financial technology industries.  (Note: Avalon Acquisition upsized its SPAC IPO at pricing on Oct. 5, 2021, to price 18 million units, up from 15 million in the prospectus, at $10 each to raise $180 million. Nearly a […]

Zhihu is the largest Q&A-inspired online community and one of the top five comprehensive online content communities in China, both in terms of average mobile MAUs and revenue in 2020, according to CIC. Zhihu is also recognized as the most trustworthy online content community and widely regarded as offering the highest-quality content in China, according to the […]

We intend to pursue opportunities created by the accelerating transition toward sustainable use of energy and natural resources. (This is the second blank-check company or SPAC formed by ArcLight Capital Partners. This SPAC (special purpose acquisition company) is incorporated in the Cayman Islands.) The renewable energy sector has emerged from a niche source of electricity […]

We intend to focus on the industries that align with the background of the sponsor with a particular emphasis placed on the healthcare sector. These industries include healthcare, industrials, consumer, media, technology and technology services. We will seek to acquire established businesses that we believe are fundamentally sound but potentially in need of financial, operational, […]